Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lisa Conboy, Sc.D.

Co-Author

Back to Details
This page shows the publications co-authored by Lisa Conboy and Sarah Ballou.
Lisa Conboy
Connection Strength
0.672
Sarah Ballou
  1. Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
    View in: PubMed
    Score: 0.248
  2. Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20.
    View in: PubMed
    Score: 0.246
  3. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.178
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.